Photo from wikipedia
To determine the extent of therapeutic inertia related to the weekly injectable glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes (T2D) in the United Kingdom. Click to show full abstract
To determine the extent of therapeutic inertia related to the weekly injectable glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes (T2D) in the United Kingdom.
Keywords:
like peptide;
injectable glucagon;
peptide receptor;
glucagon like;
therapeutic inertia;
inertia related
Journal Title: Diabetes
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!